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Abstract
Glutamate (Glu), the major excitatory neurotransmitter, elicits its action through the acti-
vation of membrane receptors and transporters expressed in neurons and glial cells. Glial 
glutamate transporters, EAAT1 and EAAT2, remove this transmitter from the synaptic 
cleft preventing an excitotoxic insult. The Notch pathway is a signaling system involved 
in neuro- and gliogenesis. Radial glia (RG) generates neurons, oligodendrocytes, and 
astrocytes in a spatial and temporal pattern, in which Notch represses neurogenesis, 
maintaining the self-renewal potential of RG. Astrogenesis depends on several stimuli, 
Notch being a master regulator of the differentiation process. The cAMP-PKA-CREB sig-
naling cascade cross talks with the Notch pathway, acting synergistically by reducing 
progenitor markers and inducing astrocytic differentiation. Notch1 mRNA is upregu-
lated in a PKA/γ-secretase/NICD/CSL-dependent manner, suggesting a feedback loop 
to keep Notch active until astrocytic differentiation is complete. Glial differentiation is 
also modulated by PKC, which acts over NICD. In RG cells and astrocytes enwrapping 
glutamatergic synapses, EAAT1 transcriptional regulation is mediated by PKC, increas-
ing Notch expression and its receptor intracellular traffic. It is clear that Notch represents 
an activity-dependent molecular key in RG cells that enable them to shape glutamatergic 
transmission through the expression of genes involved in glial/neuronal interactions.
Keywords: glia cells, signal transduction, Notch, differentiation, protein kinase C
1. Introduction
Glutamate (Glu), the major excitatory neurotransmitter in the central nervous system 
(CNS), is a key player in higher brain functions such as learning and memory, and it is also 
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involved in cell differentiation and synaptogenesis. Glu exerts its function through specific 
receptors, according to which the signal transduction pathway mechanisms are classified 
into two major groups: ionotropic (iGluRs) and metabotropic receptors (mGluRs). iGluRs 
are ligand-gated ion channels subdivided upon pharmacological and electrophysiological 
properties into NMDA, AMPA, and KA receptors. mGluRs are G protein-coupled receptors 
subdivided in accordance with their amino acidic sequence and pharmacological properties 
into three subgroups, preferentially activated by quisqualate (Quis), t-ACPD, and L-AP4, 
respectively [1–4].
Cerebellar Bergmann glia cells (BGC) are radial glia (RG) cells that are not differentiated 
into astrocytes after birth [5] and function as a neuronal reservoir [6, 7]. These cells extend 
processes through the molecular layer completely surrounding excitatory synapses between 
Purkinje cells and both parallel and climbing fibers. An exquisite and complex interplay 
between presynaptic-postsynaptic neurons and glia cells is fundamental for glutamatergic 
transmission. Glu recycling depends upon these interactions. Glu is removed from the syn-
aptic cleft by a family of electrogenic sodium-dependent transporters expressed in neurons 
and glia cells [8]. Five subtypes of transporters named excitatory amino acid transporters 
1-5 (EAAT1-5) have been characterized. The glial transporters EAAT-1 (GLAST) and EAAT-2 
(GLT-1) account for more than 80% of the Glu uptake activity in the brain [9, 10]. Within BGC, 
EAAT-1/GLAST is the predominant transporter [11].
Once internalized, Glu is metabolized to Gln via Gln synthetase and released in the vicinity 
of the presynaptic neuron through sodium-dependent neutral amino acid transporter (SNAT) 
3. Gln is then taken up by the presynaptic neuron through SNAT 2 and converted back to Glu 
by the enzyme glutaminase to be packed into synaptic vesicles completing the so-called Glu/
Gln shuttle (reviewed in [12]). It is this kind of glial/neuronal interactions that gave rise to 
what has been known in the last years as a tripartite synapse [13]. Evidence suggests that Glu 
transporters might also participate in the signaling transactions triggered by this excitatory 
amino acid. In fact, Glu regulates the uptake process in a receptor-independent manner [14]. 
More recently, it has also been reported that EAAT-1 is coupled to the Na+/K+ ATPase [15, 16] 
and to the Gln transporter SNAT3 [17].
In this context, we reviewed in this contribution the role of Notch signaling in RG focusing 
in its role in EAAT-1/GLAST regulation as a key element in the molecular mechanisms that 
support the proven glia contribution to glutamatergic neurotransmission.
2. Glutamatergic transmission: role of glial cells
Glutamate (Glu) is the major excitatory neurotransmitter in the vertebrate brain. It elicits its 
action through the activation of specific membrane receptors and transporters expressed both 
in neurons and in glial cells. Extracellular glutamate levels have to be tightly regulated in 
order to prevent Glu receptors over-stimulation that has been shown to result in neuronal 
death, phenomena commonly known as excitotoxicity. A family of sodium-dependent Glu 
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transporters particularly enriched in glial cells is responsible for the removal of this transmitter 
from the synaptic cleft [12]. These transporters, known as excitatory amino acid transporters 
(EAAT), are differentially expressed in neurons and astrocytes. EAAT3, 4, and 5 are mainly 
neuronal, whereas EAAT1 and EAAT2 are glial, although the latter one has also been found to 
be present in certain neuronal populations [18]. Once Glu has been taken up by glial cells, it 
is mostly converted to glutamine (Gln) by the glial-expressed Gln synthetase to be released in 
the vicinity of the presynaptic terminal, a process known as the Glu/Gln shuttle, in which an 
exquisite interplay between neurons and glial cells is fundamental for the proper function of 
glutamatergic transmission [12]. In this context, glutamatergic synapses are a perfect example 
of what has been lately known as a tripartite synapse [19].
3. Notch signaling
Notch signaling involves cell to cell communication and has a simple core. It initiates 
when the Notch receptor (Notch 1-4), present in the receiving-signal cell, binds its ligand 
(Jagged/Delta-like) present in the sending-signal cell. This binding promotes two sequen-
tial proteolytic cleavages on the Notch receptor: the first is mediated by the protease 
ADAM10/TACE (tumor necrosis factor α converting enzyme) to generate the membrane-
tethered intermediated Notch extracellular truncation (NEXT). The second cleavage is 
mediated by the γ-Secretase enzyme on NEXT, to release the signal effector Notch intra-
cellular domain (NICD) into the cytoplasm. NICD is translocated to the nucleus where it 
binds the transcription factor CSL (CBF1/RBPJκ in vertebrates, suppressor of hairless in 
Drosophila, Lag-1 in C. elegans) to activate what is known as the canonical Notch pathway. 
In the absence of NICD, CSL associates with the ubiquitous co-repressors (Co-R): SKIP, 
CtBP/Hairless, SMRT, CIR, FLH1C/KyoT2, SHARP/MINT and Gro/TLE proteins, and his-
tone deacetylases (HDACs) to halt the transcription of Notch target genes. Once NICD 
binds CSL, allosteric changes may occur on CSL that facilitates displacement of transcrip-
tional repressors. The transcriptional co-activator Mastermind (MAM) then recognizes the 
NICD/CSL interface, and this tri-protein complex recruits additional co-activators (Co-
A) to promote transcription of target genes, as the astroglial markers shown in Table 1 
[20–27].
The noncanonical Notch signaling pathway is CSL-independent and can as well be either 
ligand-dependent or independent. Nevertheless, one has to keep in mind that the NICD/
CSL complex is the major effector of Notch signaling. Several pieces of evidence have dem-
onstrated that the Notch pathway may signal independently of CSL. It was first reported that 
Notch could signal via the RING-domain of E3 ubiquitin ligase Deltex1 (DTX1) [28]. It has 
also been shown that NEXT binds NICD on its ankyrin repeats [29], leading to its nuclear 
translocation. It has been documented as well that the NICD/DTX1 complex interacts with the 
transcriptional co-activator p300 inhibiting the transcriptional activation of the neural-specific 
transcription factor MASH1 [30]. As it will be described later, other genes important for astro-
glial differentiation are also targets of NICD/DTX (Table 1).
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4. Notch pathway signaling in astroglial differentiation
Notch pathway is a pivotal signaling system during neuro- and gliogenesis in the central 
nervous system (CNS) [24, 25]. Primary neural stem cells (NSC) are radial glia (RG) during 
development, characterized by the expression of astroglial markers such as the astrocyte-
specific glutamate/aspartate transporter (GLAST), the brain lipid-binding protein (BLBP), 
and tenascin C (TN-C) [31]. RG cells generate neurons, oligodendrocytes, and astrocytes in a 
characteristic spatial and temporal pattern [31]. In this context, the Notch pathway plays an 
essential role repressing neurogenesis and maintaining the self-renewal potential of RG.
On the neurogenic phase, RG divide asymmetrically for auto-renewal and generation of 
neurons or neuron-restricted intermediate progenitor cells (nIPCs, transit amplifying cells), 
which in turn populate the subventricular zone (SVZ) in the cortex. The newborn neurons 
migrate along parental RG fibers, even though RG are dividing [31]. The Notch pathway 
plays an important role during the neurogenic phase in several ways. In the cortex, recent 
findings suggest that Notch signaling among SVZ nIPCs and between nIPCs and RG is impor-
tant in the regulation of progenitor proliferation and in the inhibition of precocious neuronal 
differentiation. RG receives Notch signaling to activate Hes1 and Hes5 transcription factors, 
which down-regulate pro-neuronal genes such as neurogenin 1 (Ngn1), Mash1, and Math. 
Target Function Reference
Canonical pathway
(NICD/
RBPJκ-dependent)
Hes1/Hes5 Down-regulate pro-neural transcription factors, 
as Mash1, Math, and Neurogenin; which in turns 
regulate neural protein expression (p. ej.MAP2)
[72]
Glutamate aspartate 
transporter (GLAST)
Glutamate transport This work
(Glial fibrillary acidic 
protein (GFAP)
Principal protein (most abundant) forming an 
intermediate filament in mature astrocytes. Is 
important in radial glia cytoskeleton.
[50]
Binding lipid-binding 
protein (BLBP)
Hydrophobic protein member from the family FABP 
(Fatty acid–binding protein). Binds to ligands of 
nuclear receptors and participate regulating their 
transcriptional activity.
[32, 33]
Vimentin Most abundant protein forming intermediate 
filaments in immature astrocytes and radial glia
[73]
Noncanonical
(NICD/
RBPJκ-independent)
erbB2 Tyrosine kinase receptor [33]
Slug Zinc-finger transcription factor that regulates neural 
crest formation and delamination
[74]
β-catenin/Wnt 
signaling
Wnt/β-catenin signaling; Notch binds and titrates 
levels of the obligate Wnt-signaling component active 
β-catenin.
[75, 76]
BMP4 Induce neural crest cells from the neural plate. Bmp4 
can induce Slug expression and subsequent neural crest
[74, 77]
Table 1. Targets of Notch signaling pathway in central nervous system development.
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At the same time, Ngn1 becomes an astrogenesis inhibitor through the sequestration of p300/
CBP, a key inducer of astrocyte differentiation [29].
In the cerebellum and in the immature RG, it has been demonstrated that Notch1 is activated by 
Jagged1 on newborn neuron progenitors; this interaction regulates the molecular and morpho-
logical differentiation of RG, through the transcriptional activation of BLBP and the erbB2 recep-
tor tyrosine kinase. This effect is mediated by two downstream mechanisms, one that depends 
on RBPJκ (canonical activation) and the other depending on Deltex1 (DTX1) (noncanonical acti-
vation). In this manner, the induced erbB2 receptor interacts with its ligand neuregulin, present 
on neuronal progenitors, to facilitate cell migration through RG fibers (Figure 1) [32, 33].
After the neurogenesis period, at the end of embryonic development, most of the RG cells 
have lost their ventricular attachment and migrate toward the cortical plate by a process of 
somal translocation. In mammals, the majority of RG cells are transformed into astrocytes. 
During this period, astrocytic and oligodendrocytic intermediate precursors are also gener-
ated (aIPCs and oIPCs). Some studies suggest the presence of multipotent and bipotent pro-
genitors, and perhaps astrocyte-restricted progenitors in the neonatal SVZ [34].
Astrogenesis depends on several stimuli, being the Notch pathway a master regulator of the 
differentiation process. During the gliogenic phase, RG progenitors gain competence to gen-
erate astrocytes due to the activity of growth factors such as basic fibroblast growth factor 
(bFGF) and epidermal growth factor (EGF). This gain of competence allows them to respond 
to specific gliogenic signals acting at the extracellular level to activate astrocyte markers such 
as glial fibrillary acidic protein (GFAP), S100β, aquaporin 4, glutamate transporters (GLT-1, 
EACC1, and GLAST), and aldehyde dehydrogenase 1 family, member L1 (AldhL1) [35–39]. 
Before the astrocyte-marker promoters can respond to gliogenic signals, a chromatin epigen-
etic remodeling must occur. Notch canonical activation on RG induces expression of nuclear 
factor 1A (NFA1), an inhibitor of the DNA methyltransferase 1 (DNMT1). DNMT1 keeps 
STAT3 site of GFAP promoter methylated and inactive [40, 41].
The extracellular signals are provided by neurotrophic cytokines such as ciliary neurotrophic 
factor (CNTF), leukemia inhibitory factor (LIF), and cardiotrophin-1 (CT-1) secreted by new-
born neurons. These cytokines activate heterodimeric cell surface receptors composed of two 
subunits named LIFRβ and gp130, which in turn activate to members of the JAK family of tyro-
sine kinases that result in the phosphorylation and nuclear translocation of signal transducer 
and activator of transcription (STAT) proteins. In RG, two of these proteins, STAT1 and STAT3, 
act on specific sites in the promoters of the astroglial genes GFAP and S100β to stimulate their 
transcription during the astrocyte differentiation process. Neural progenitors also respond to 
different neurotrophic factors from the bone morphogenetic proteins (BMP) family to generate 
astrocytes. In this case, BMP2 and BMP4 act on heterotrimeric receptors, which activate SMAD 
transcription factors. These, in turn, interact with activated STAT proteins to synergistically 
stimulate transcription of glial-specific genes during astrocyte differentiation [42–47].
Another estrogen signal is the activation of the seven transmembrane domain G protein-cou-
pled receptors by the pituitary adenylate cyclase-activating polypeptide (PACAP), triggering 
the differentiation of astrocytes by increasing intracellular cAMP and activating the cAMP-
dependent protein kinase (PKA), which translocates into the nucleus to phosphorylate and 
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Figure 1. Notch pathway regulates astrocytic differentiation. (A) In timed cell genesis, a series of orchestrated events are 
activated to regulate cell differentiation; the Notch pathway is used as a signaling system during embryonic development 
and regulates different cell markers in astrocyte differentiation, such as Hes genes, GFAP and S100B. (nIPC/aIPC cell 
stands for neural or astrocytic intermediate precursor cell). (B) Neuroepithelial cells in early development proliferate 
by asymmetric cell division to generate more neuroepithelial cells (progenitor expansion phase). As brain development 
proceeds, neuroepithelial cells elongate to convert into radial glial (RG) cells and guide neuronal migration. Later, RG 
can divide asymmetrically to generate neuron, astrocyte, or oligodendrocyte intermediate progenitor cells.
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activate the cAMP-response element-binding protein (CREB) [42–48]. In a glial precursor-like 
model, C6 cells, cAMP-PKA-CREB activation leads to increase autocrine IL-6, which in turn 
activates STAT3, which induces GFAP promoter activation [49]. In the same model, the cAMP-
PKA-CREB signaling cascade cross talks with the Notch pathway, and together they act syn-
ergistically to reduce the progenitor marker (Nestin) and to induce astrocytic differentiation; 
measured by induced astrocytic markers (GFAP, S100β, and GLAST) and glutamate uptake. 
In this context, Notch1 mRNA is up-regulated in a PKA/γ-secretase/NICD/CSL-dependent 
manner, suggesting the establishment of a feedback loop to keep Notch pathway active until 
astrocytic differentiation is complete [50]. It is not surprising that the Notch pathway interacts 
with other signaling cascades to complete astrocytic differentiation. A bioinformatic analysis 
of promoters for GFAP, S100β, GLAST, and Notch1, reveals specific sites for CREB, STAT3, 
and CSL transcription factors, suggesting that these three pathways, cAMP-PKA/JAK-STAT3/
Notch, cooperate to induce the transcription of astrocyte markers. Certainly, at this stage, 
other crosstalk interactions cannot be discarded.
5. Glial differentiation and the Ca2+/diacylglycerol-dependent 
protein kinase (PKC)
As already mentioned, glial differentiation is modulated by extracellular signals, growth fac-
tors, hormones, cytokines, neurotrophins, and neurotransmitters that activate different signal 
pathways. PKC is one of the major mediators of these extracellular signals. The structure of 
this family of protein kinases contains a highly conserved catalytic domain and a regulatory 
domain (C1-C4 domains) responsible for its inactive conformation. Regulatory domains are 
separated by variable regions susceptible to proteolytic cleavage and essential for activation 
and conformational changes. The PKC family comprises 11 isoforms and is organized in three 
subfamilies: classical, novel, and atypical isoforms described in Table 2 [51–54].
PKC is highly expressed in the brain, with a significant role of this kinase in the function of 
neuronal and glial cells. The role of PKC in glial cells has been demonstrated in different 
reports, and PKC-activator PMA as well as the different PKC inhibitors, modify the cell mor-
phology, proliferation, and differentiation [55–58]. Differential expression of PKC isoforms 
has been reported during neuronal development as four PKC isoforms are expressed in neu-
ronal primary cultures of rat cerebellum. In contrast, only two isoforms, αPKC and βII PKC, 
are present in glial cultures [59, 60]. Brodie et al. reported that in undifferentiated C6 cells, the 
PKC isoforms θ, μ, ζ, and λ are present; however, the cAMP-dependent differentiated C6 cells 
expressed significantly lower levels of PKC α and PKC δ and higher levels of PKC γ, η, and θ.
Concerning PKC and glial cell function, overexpression of the β and γ isoforms increases 
GFAP levels, as a response to exposure to the PKC activator phorbol 12-myristate 13-acetate 
(PMA) treatment. Glutamine synthetase (GS) levels increase with PKC γ overexpression and 
decrease with PKC δ. Therefore, it is plausible that PKC α and δ provide negative signals for 
astrocytic differentiation, while PKC β and γ induce astrocyte differentiation [51].
However, it has also been documented that undifferentiated C6 cells express the α, βΙΙ, γ, δ, ε, 
and ζ PKC isoforms and that long-term PKC inhibition after staurosporine treatment, which 
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leads to differentiation, results in βII decrease, γ increase and ε translocation from the mem-
brane to the cytosol [55]. Similar results were reported in the C6 cell differentiation process with 
dbcAMP [61]. It is clear that the molecular mechanisms triggered by glia differentiation agents 
are different, but that the various PKC isoforms are critically involved in the overall process.
In contrast, Watanabe et al. recently reported that overexpression of PKC βII synergistically 
enhanced differentiation in the presence of 1 nM of PACAP. These results indicate that the 
β isoform of PKC is important in PACAP-induced differentiation of mouse embryonic NSCs 
into astrocytes via the PAC1 receptor, resulting in activation of phospholipase C, followed 
by PKC activation. This latter observation was confirmed in NSCs. The cells were exposed to 
2 nM PACAP, resulting in a transient increase in the βII isoform, that returned to basal levels 
by day 4, whereas the levels of PKC α increased linearly up to day 6 [62].
RG cells and astrocytes are involved in regulation of the brain microenvironment, and glu-
tamate transporters control the extracellular levels of this neurotransmitter. Regulation of 
glutamate uptake involves several factors like neuronal interactions, glutamate, cAMP, and 
phorbol esters. GLAST is the major glutamate transporter expressed in RG cells. Interestingly, 
GLAST expression is regulated via PKC through the reduction of its protein and mRNA lev-
els. Our work group demonstrated that chglast transcriptional regulation is mediated by PKC, 
especially the α and ε isoforms, which activate the AP-1 transcription factor [56, 63, 64].
6. Another Notch in the belt: PKC/Notch cross talk in glial 
differentiation
The Notch signaling pathway plays an important role in the control of cell fate during 
developmental processes. Several reports have shown that Notch-induced signaling inter-
acts with other signaling pathways, such as NF-κB, the mitogen-activated protein kinase 
(MAPK) pathway, and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway [65–67]. 
Although there are only a few reports describing the crosstalk between Notch and PKC 
signaling during glial differentiation, some connections have been described so far. The 
most direct example concerns the direct PKC action over NICD: Kim et al. found that PKC δ 
down-regulates NICD transcriptional activity in a kinase-independent manner. The mecha-
nism involves the inhibition of the nuclear localization of NICD, most possibly through a 
physical association between NICD and PKCδ causing the dissociation of NICD from target 
gene promoters like Hes5 [67].
Isoforms Activity
Classical isoforms α, βΙ, βΙΙ, γ Dependent on DAG, PS, and Ca2+
Novel PKC isoforms δ, ε, θ, η, μ Bind DAG, PS, and calcium-independent
Atypical PKC isoforms ι/λ, ξ Bind PIP3, calcium-independent and do not require DAG
Diacylglycerol (DAG), phosphatidylserine (PS), phosphatidylinositol 3-phosphate (PIP3) [53, 78].
Table 2. PKC classification.
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In another example, PMA increased the expression of Notch1 in a PKCε-dependent man-
ner in the context of astrocytic differentiation, and this is to say that in the course of PKC-
dependent astrocyte differentiation, an increase in Notch levels is found. In fact, serine 729 
PKCε phosphorylation is as essential for the differentiation process. This data suggests that 
Notch1 is a plausible mediator of PKCε in astrocytic differentiation [68]. In the same line, 
Xu et al. reported that morphine-dependent astrocytic differentiation of neuronal progenitor 
cells (NPC) involves ERK via PKCε and TRBP phosphorylation that leads to miR-181a matu-
ration, thus regulating the expression of Prox1 and Notch1 [69].
More recently, it has been demonstrated that atypical PKC isoforms participate in asymmetric 
cell division when glial differentiation starts. Sjoqvist et al. demonstrated that PKCζ regulates 
the Notch pathway by phosphorylation and regulation of Notch receptor traffic. When Notch 
signaling is active (after ligand stimulation or after expression of an activated membrane-
tethered form of Notch), PKCζ enhances the production of NICD and shifts the localization 
of Notch from late endosomes to the nucleus, leading to an elevated Notch signaling. In con-
trast, when the Notch receptor is not activated, PKCζ interacts with the receptor to induce a 
shift in receptor distribution from the plasma membrane to intracellular vesicles [70]. In C6 
glioma cells, increased cAMP levels promote astrocytic commitment with a sustained aug-
mentation of Notch activity, as detected by nuclear translocation of its intracellular domain 
portion (NICD) and its transcriptional activity [50]. The cAMP effect is mediated through the 
activation of the γ-secretase complex, responsible for Notch cleavage as demonstrated by its 
sensitivity to PKA inhibitors. As expected, Notch cleavage and nuclear translocation result in 
the upregulation of the mRNA levels of one of its target genes, the transcription factor Hair, 
and enhancer of split 5. Moreover, glutamate uptake activity, expression of astrocytic mark-
ers (genes responsible for glial progenitor cell fate decision) such as the glial fibrillary acidic 
protein, the S100beta protein, and GLAST, are also enhanced in cAMP-exposed cells [50]. 
Interestingly, polychlorinated biphenyls (PCBs) disturb the cAMP-induced astrocytic differ-
entiation of C6 cells via the PKC isoforms γ, β2, δ and ε [58]. Additionally, PMA promotes 
adult neurogenesis by inducing neural progenitor cell proliferation in vitro in NPCs obtained 
from the SVZ of 7-day postnatal mice [71].
To support a plausible role of a crosstalk between PKC and Notch pathways in embryonic 
glial differentiation, we used chick Bergman radial glia from cerebellum (BGC) at day 14 of 
embryonic development and stimulated PKC using TPA. In this system, it was observed that 
PKC activation increased NICD/RPBJκ-dependent transcription, measured by a reporter con-
struct that senses directly the CSL activity (Figure 2A). This effect could be mediated by the 
classical PKC isoforms (α, β1, β2, and γ) and/or the novel isoforms (δ and ε), as it was observed 
when the specific inhibitor bisindolylmaleimide 1 (Bis1). The same effect was observed over 
a Hes1-responsive reporter (Figure 2A, right). Also, the MAPK/ERK pathway plays a role in 
PKC-mediated NICD/RPBJκ activation, as demonstrated when specific MAPK/ERK inhibi-
tors (U0126, PD98059, and SB202190) were used in co-treatment with TPA (Figure 2A). In 
contrast, treatment of BGC with TPA, down-regulates astrocytic biomarkers such as GFAP, 
GS, GLAST, FABP7, and Notch1 mRNA levels, and keeps Nestin, a progenitor marker, 
up-regulated (Figure 2B). Our results suggest that the activation of PKC induces NICD/RBPJκ 
dependent transcriptional activation by a yet-to-be characterized mechanism, that perhaps 
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Figure 2. PKC/MAPK signaling activates Notch pathway in cultured Bergmann glia cells (BGCs). (A) In order to determine 
the role of the Notch/PKC signaling pathway in BGCs, cells (primary culture) were transfected with the reporter plasmid 
4xwtCBF1Luc (containing four repeated sequences for RBPJκ elements) or Hes1 promoter (a Notch effector gene) with 
Lipofectamine R 2000; after harvesting, the luciferase reporter activity was measured. 24 h post-transfection, the BGCs 
were treated with 100 nM TPA for other 24 h, where we showed that promoter activity increased five-fold in relation 
with nontreatment cells, and TPA induces the Notch signaling response. To analyze the signal pathway involved in 
Notch activation, BGCs were treated with 40 μM BisI (a PKC inhibitor), 50 μM U0126 (a MAPK1 inhibitor), PD (PD8059, 
a MAPK1 inhibitor), or SB20 (SB202190, a specific ERK inhibitor) 30 min prior to TPA, as indicated in the figure. Note 
that both PKC and MAPK inhibitors prevent Notch pathway activation. Results are presented as fold expression relative 
to nontreated cells. Data represent mean values ± SE (n = 3). Data were analyzed by a one-way ANOVA with a post hoc 
Dunn’s test. *** p < 0.001; ### p < 0.003; #, p < 0.05. (B) qRT-PCR was performed to analyze expression of Notch pathway 
targets, and BGC cultures were treated or not with TPA (100 nM TPA) at different times. Total RNA was extracted 
to amplify GFAP, GLAST, vimentin, glutamine synthetase (astrocytic markers), and nestin (radial glial marker) with 
the KAPA SYBR FAST one-step qRT-PCR kit. Our data suggest that TPA downregulates GLAST, GFAP, and GS and 
upregulates nestin; this evidence indicates that the Notch pathway is important in the radial glial fate.
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is related to regulation of NICD routing and trafficking [67, 70]. The NICD/RBPJκ complex 
induces Hes1 expression, a well-known neurogenesis inhibitor. On the other hand, PKC acti-
vation blocks astrogenesis, perhaps modulating the access of NICD/RBPJκ to the astrocytic 
markers’ promoters, like GFAP, which is dependent on Notch activation. In BGC, PKC activa-
tion regulates several genes that are closely related to glial function and induces radial glial 
phenotype as TPA down-regulates GLAST, GFAP, and GS and upregulates Nestin, PKCα, or 
PKCε (PKC �2).
6.1. Notch pathway in CNS: some aspects of clinical relevance
A plethora of pathological scenarios in the CNS are the result of neuronal degeneration. 
This cell loss needs to be compensated to keep the neural circuits working. In this con-
text, neural stem cells can be differentiated into precise neuronal subtypes, but a com-
mon fact is that Notch signaling promotes astrocyte differentiation rather than neuronal 
differentiation. Therefore, Notch inhibition is an alternative therapeutic option in the 
clinical approach. Examples of the possible application of inhibiting Notch are presented 
in the Table 3.
Pathological context/
biological system
Targeted neural 
stem cells
Notch signaling role and possible therapeutic approach Ref
Blockage of notch pathway in neural adult stem cells to promote neurogenesis
Glioblastoma 
(multiforme or grade IV 
astrocytoma)
Glioblastoma cells 
(GB)
Pharmacological inhibition of Notch pathway selectively 
inhibited tumor growth. Conversely, activation of Notch 
signaling promotes cell proliferation and colony formation 
in the human GB cell line. Notch1 promotes invasive 
migratory properties of GB cells by stimulating β-catenin 
and NF-κB signaling and mediates GB cell proliferation and 
survival through the Akt-mammalian target of rapamycin 
(mTOR) signaling axis. Treatment with γ-secretase inhibitors 
reduces neurosphere growth, and inhibits xenograft tumor 
growth through decreased Akt and STAT3 phosphorylation. 
Combination of Notch inhibitor MRK003 and Akt inhibitor 
MK-2206 effectively inhibited GB invasiveness.
[79]
Lineage-specific 
differentiation of NPCs
Hippocampal 
progenitor cells 
(HPC)
Phosphorylation of TAR RNA-binding protein together with 
miR-181a maturation, as well as Dicer activity, is involved in 
morphine-induced astrocyte-preferential differentiation of 
HPC.
[69]
Alzheimer’s disease 
(AD)
Amyloid precursor 
protein (APP)
Human neural 
progenitor cells 
(HNPC)
Activation of IL-6/gp130 and Notch signaling pathways in glial 
differentiation of HNPCs may cause problems in maintaining 
normal brain function and may contribute to AD pathology. 
Treatment with sAPP increased expression levels of GFAP in 
NT-2/D1 cells along with the generation of Notch intracellular 
domain (NICD) and expression of Hairy and enhancer of split 
1 (Hes1), indicating that glial differentiation may aid in the 
development of novel therapeutic strategies for AD.
[80] 
[81]
Blood-brain barrier, 
pathology
Brain endothelial 
cells
Neuron-derived Dll1 activates Notch signaling and is essential 
for brain endothelial cells’ survival as wells as blood-brain 
barrier, selective substance crossing; physiology, pathology, 
and drug development
[82]
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Pathological context/
biological system
Targeted neural 
stem cells
Notch signaling role and possible therapeutic approach Ref
Traumatic brain injury 
(TBI), inflammation and 
apoptosis and brain 
edema
Cerebral cortices 
response
Inhibition of Notch signaling by crocin, an extract of saffron, 
has a neuroprotective effect against TBI, since in this type of 
injury an upregulation of Notch intracellular domain (NICD) 
and Hes1 mRNA levels is present, decreasing microglial 
activation and release of several pro-inflammatory cytokines.
[83]
Increased differentiation 
of neural progenitor cells 
when co-cultured with 
astrocytes lacking glial 
fibrillary acidic protein 
(GFAP) and vimentin
Neural progenitor 
cells
Astrocytes negatively regulate neurogenesis through Notch 
pathway; endocytosis of Notch ligand Jagged1 in astrocytes 
and Notch signaling from astrocytes to neural stem/progenitor 
cells depends on intermediate filament proteins GFAP and 
vimentin.
[84]
Experimental 
autoimmune 
encephalomyelitis 
(failure to repair 
demyelination) as 
Multiple Sclerosis model 
(mice)
Oligodendrocyte 
precursor cells
Gamma-secretase inhibition of Notch signaling enhances tissue 
repair.
Notch pathway inhibits oligodendrocytes differentiation 
and hampers their ability to produce myelin during CNS 
development.
[85, 
86]
Seizure as a serious 
complication of stroke
Neurons in 
cortex and 
hippo-campus
In a global cerebral ischemia model (GCI), there is augmented 
excitatory synaptic neurotransmission by upregulating 
glutamate receptor subunits (GluN2A, GluA1) and cotransporter 
NKCC1, but there is attenuated inhibitory synaptic 
neurotransmission by down-regulating amino butyric acid 
(GABA), and neuronal K-Cl cotransporter. Aberrant activation 
of Notch signaling is involved in poststroke seizures, as NICD 1 
and 2 were upregulated in the cerebral cortex and hippocampus 
post-GCI. DAPT treatment normalized the homeostasis of 
excitatory and inhibitory synaptic neurotransmission.
[87]
Familial and idiopathic 
Parkinson’s disease (PD)
Differentiated 
dopaminergic 
neurons
Leucine-rich repeat kinase 2 (LRRK2) complex promotes 
recycling of Notch ligand Delta-like 1 (Dll1)/Delta (Dl) through 
modulation of endosomal trafficking and negatively regulates 
Notch signaling through cis-inhibition by stabilizing Dll1/Dl, 
accelerating neural stem cell differentiation; alteration of Notch 
signaling in mature neurons is a component of PD etiology 
linked to LRRK2.
[88]
Notch signaling in neurodegenerative diseases and pathological glutamate mediated plasticity
Dopamine release in the 
striatum, individual’s 
susceptibility to 
neuropsychiatric disease
Neuronal cells RBP-J deficiency drastically reduced dopamine release in 
the striatum and caused a subtle decrease in the number of 
dopaminergic neurons as Notch/RBP-J signaling regulates 
dopamine responsiveness in the striatum.
[89].
Length, polarity, and 
synaptogenesis
Spiral ganglion 
neurons (SGNs)
DNER modulates length, polarity and synaptogenesis via 
the Notch signaling pathway. DNER was expressed in spiral 
ganglion neurons exhibiting significant polarity in early 
differentiation stages; DNER expression gradually decreased 
until polarity was lost on week 35. Silencing DNER expression 
altered the polarity of differentiated neurons and these cells 
exhibited significantly reduced dendritic length.
[90]
Table 3. Notch signaling in cell therapy.
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7. Conclusion
Glia cells play an active role in glutamatergic transmission due to their compulsory inter-
vention in the recycling of this excitatory neurotransmitter. The Notch signal transduction 
pathway is critically involved in the gene expression regulation of the major excitatory amino 
acid transporter expressed in early stages of astrocyte differentiation and in RG in the adult 
brain. Notch signaling involves the activation of diverse isoforms of PKC. Glial differentiation 
can be mediated by PKC and its isoforms, which act over NICD, increasing Notch expression, 
regulating several astrocytic markers related to glial function, and inducing the radial glial 
phenotype.
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ADAM10/TACE Tumor necrosis factor-α converting enzyme
AldhL1 aldehyde dehydrogenase 1
bFGF Basic fibroblast growth factor
BGC Chick Bergmann Radial glia
BisI Bisindolylmaleimide
BLBP Brain lipid-binding protein
BMP Bone morphogenetic proteins
cAMP Cyclic adenosine monophosphate
CIR Corepressor interacting with RBPJ 1
CNS Central nervous system
CNTF Ciliary neurotrophic factor
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CREB cAMP-response element-binding protein
CT-1 Cardiotrophin-1
DNMT1 DNA methyl transferase 1
DTX1 Deltex1
EAATs Excitatory amino acid transporters
EACC1 Excitatory amino acid transporter 1
EGF Epidermal growth factor
ErbB2 also known as HER2, Human epidermal growth factor receptor 2
ERK Extracellular signal-regulated kinases
FABP7 Fatty acid–binding protein 7
GFAP Glial fibrillary acidic protein
GLAST Glutamate aspartate transporter
GLT-1 Glutamate transporter 1
GS Glutamine synthetase
HDAC Histone deacetylases
LIF Leukemia inhibitory factor
LIFRβ Leukemia inhibitory factor receptor β
MAM Mastermind
MAP 2 Microtubule-associated protein 2
MAPK Mitogen-activated protein kinase
MASH Mammalian achaete-scute homolog-1
NEXT Notch extracellular truncation
NFA1 Nuclear factor 1A
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
Ngn1 Neurogenin 1
NICD Notch intracellular domain
NIPC Intermediate progenitor cell
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PACAP Pituitary adenylate cyclase-activating polypeptide
PI3K Phosphatidylinositol 3-kinase
PKA cAMP-dependent protein kinase
PKC Protein kinase C
PMA Phorbol 12-myristate 13-acetate
RBPJκ Recombining binding protein
RG Radial glia
SMRT Thyroid-hormone receptors
STAT3 Signal transducer and activator of transcription 3
SVZ Subventricular Zone
TN-C Tenascin C
TPA 12-O-tetradecanoylphorbol 13-acetate
TRBP TAR RNA-binding protein
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